Institute of Biomedical Research Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MRES research report →
Companymrescorp.com
Institute of Biomedical Research Corp. provides biomedical research and analytical services in Montenegro and internationally. Its services include regulatory control of industrial activities and products; scientific surveillance of the living environment; research and development of biomedical products and technologies; regulatory evaluation and certification of biomedical products; fundamental scientific research; and development of new diagnostic methods and experimental medical treatments.
- CEO
- Drasko D. Pekovic
- IPO
- 2004
- Employees
- 7
- HQ
- Podgorica, ME
Price Chart
Valuation
- Market Cap
- $3.79M
- P/E
- -2.30
- P/S
- 80.62
- P/B
- 14.35
- EV/EBITDA
- -7.11
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 37.47%
- Op Margin
- -1108.75%
- Net Margin
- -3511.16%
- ROE
- -387.66%
- ROIC
- -20.59%
Growth & Income
- Revenue
- $49.49K · 9.79%
- Net Income
- $-632,720 · -147.58%
- EPS
- $-0.00 · -133.33%
- Op Income
- $-756,513
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.02
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.19
- Avg Volume
- 1.16M
Get TickerSpark's AI analysis on MRES
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our MRES Coverage
We haven't published any research on MRES yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MRES Report →